Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 56,692,000 $ 67,325,000
Prepaid expenses and other current assets 2,863,000 1,533,000
Total Current Assets 59,555,000 68,858,000
Property and equipment, net 302,000 101,000
Restricted cash 103,000  
Right of use asset 1,338,000 1,383,000
In-process research and development 21,869,000  
Goodwill 5,809,000  
Deposits and other assets 23,000 23,000
Total Assets 88,999,000 70,365,000
Current Liabilities:    
Accounts payable 1,354,000 524,000
Accrued expenses 1,535,000 1,928,000
Accrued employee benefits 423,000 978,000
Contingent consideration, current portion 7,470,000  
Loans Payable-current 68,000  
Lease liability 126,000 124,000
Total Current Liabilities 10,976,000 3,554,000
Non-current Liabilities    
Non-current contingent consideration 4,688,000  
Loan Payable - Long term 229,000  
Deferred tax liabilities, net 3,728,000  
Lease liability - long term 1,351,000 1,403,000
Total Liabilities 20,972,000 4,957,000
Commitments and Contingencies
Stockholders' Equity (Deficit):    
Common stock, $0.001 par value; 200,000,000 shares authorized, 158,440,168 issued and 158,437,840 outstanding at March 31, 2022 and 132,044,866 issued and 132,042,538 outstanding at December 31, 2021 158,000 132,000
Additional paid-in capital 343,245,000 336,560,000
Accumulated other comprehensive loss 181,000  
Accumulated deficit (275,557,000) (271,284,000)
Total Stockholders' Equity 68,027,000 65,408,000
Total Liabilities and Stockholders' Equity $ 88,999,000 $ 70,365,000